Asset Management One Co., Ltd. Bei Gene, Ltd. Transaction History

Asset Management One Co., Ltd.

  • $33.6 Billion
  • Q3 2025

A detailed history of Asset Management One Co., Ltd. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 19,910 shares of BGNE stock, worth $4.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,910
Previous 20,453 2.65%
Holding current value
$4.51 Million
Previous $4.64 Million 2.65%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025
SELL
N/A
-543 Reduced 2.65%
19,910 $4.51 Million
Q3 2024

Oct 30, 2024
BUY
$143.93 - $224.51 $373,210 - $582,154
2,593 Added 14.52%
20,453 $4.59 Million
Q2 2023

Jul 31, 2023
BUY
$178.3 - $266.78 $245,519 - $367,356
1,377 Added 8.35%
17,860 $3.18 Million
Q4 2022

Feb 06, 2023
SELL
$125.51 - $229.3 $1.38 Million - $2.52 Million
-10,972 Reduced 39.96%
16,483 $3.63 Million
Q3 2022

Nov 04, 2022
BUY
$131.8 - $202.24 $215,493 - $330,662
1,635 Added 6.33%
27,455 $3.7 Million
Q2 2022

Jul 29, 2022
SELL
$121.11 - $216.05 $15,744 - $28,086
-130 Reduced 0.5%
25,820 $4.18 Million
Q1 2022

May 13, 2022
BUY
$146.52 - $269.56 $145,787 - $268,212
995 Added 3.99%
25,950 $4.89 Million
Q4 2021

Feb 09, 2022
SELL
$248.56 - $389.34 $600,023 - $939,866
-2,414 Reduced 8.82%
24,955 $6.51 Million
Q3 2021

Nov 02, 2021
BUY
$249.6 - $403.14 $96,345 - $155,612
386 Added 1.43%
27,369 $9.93 Million
Q2 2021

Aug 03, 2021
SELL
$292.75 - $367.01 $365,352 - $458,028
-1,248 Reduced 4.42%
26,983 $9.26 Million
Q1 2021

May 14, 2021
SELL
$260.64 - $382.12 $186,878 - $273,980
-717 Reduced 2.48%
28,231 $9.83 Million
Q4 2020

Feb 12, 2021
SELL
$221.31 - $316.61 $53,778 - $76,936
-243 Reduced 0.83%
28,948 $7.09 Million
Q3 2020

Nov 13, 2020
BUY
$189.18 - $286.44 $14,756 - $22,342
78 Added 0.27%
29,191 $8.36 Million
Q2 2020

Aug 14, 2020
BUY
$123.9 - $195.41 $281,376 - $443,776
2,271 Added 8.46%
29,113 $5.49 Million
Q1 2020

May 14, 2020
BUY
$121.84 - $173.19 $41,425 - $58,884
340 Added 1.28%
26,842 $3.3 Million
Q4 2019

Feb 14, 2020
BUY
$115.78 - $208.34 $95,055 - $171,047
821 Added 3.2%
26,502 $4.39 Million
Q3 2019

Nov 14, 2019
BUY
$120.61 - $148.29 $33,408 - $41,076
277 Added 1.09%
25,681 $3.15 Million
Q2 2019

Aug 14, 2019
BUY
$113.99 - $146.86 $235,959 - $304,000
2,070 Added 8.87%
25,404 $3.15 Million
Q1 2019

May 15, 2019
SELL
$122.82 - $151.83 $3.61 Million - $4.47 Million
-29,432 Reduced 55.78%
23,334 $3.08 Million
Q4 2018

Feb 13, 2019
BUY
$107.01 - $175.15 $5.65 Million - $9.24 Million
52,766 New
52,766 $7.4 Million

Others Institutions Holding BGNE

# of Institutions
275
Shares Held
32.2M
Call Options Held
113K
Put Options Held
106K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $23.5B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email